Mount Sinai Researchers Establish Link Between Amyotrophic Lateral Sclerosis and the Body’s Response to Viral Infection
In a recent study titled “Senataxin suppresses the antiviral transcriptional response and controls viral biogenesis,” published…
Articles by Margarida Azevedo, MSc
FDA Grants Orphan Drug Status to AB Science’s Masitinib Drug For ALS
Pharmaceutical company AB Science SA received orphan drug designation from the U.S. Food and Drug…
KTH Royal Institute of Technology Reveals 3 Proteins Associated with ALS Progression
A recent study from Sweden’s KTH Royal Institute of Technology (KTH) revealed three proteins that are associated with the…
Biogen Idec’s Rebranding Includes New Focus on ALS
Massachusetts-based pharmaceutical company Biogen Idec Inc. has decided to rebrand the company with a shorter name and a new…
Hypermethylation May Be Neuroprotective in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
A research team at Penn Medicine recently found that hypermethylation is able to inhibit the development of Amyotrophic…
Results Published From Phase I Trial on Human Neural Stem Cell Transplantation in Patients With Amyotrophic Lateral Sclerosis
Results from a recent Phase I clinical trial in patients with Amyotrophic Lateral Sclerosis (ALS) showed a safe cell…
ALS Association Inaugurates Nevada Chapter
The ALS Association is inaugurating its new Nevada Chapter after the group joined 39 affiliates throughout the country to work in…
Augie’s Quest to Host Bash Reunion for ALS Therapy Development Institute
The Augie’s Quest initiative is hosting a 10 Year Reunion Bash on Friday, March 13. The event, which is being organized together…
“My-Own-Voice” Speech System Presented at CSUN Conference
‘My-own-voice,’ a system for patients who are losing their ability to speak due to diseases such as…
Clinical Trial on the Efficacy of a Diaphragm Pacing System in ALS
A new Phase 2 clinical trial (ClinicalTrials.gov Identifier: NCT01938495) titled “Multi-Center, Randomized Controlled…